Nα-Boc-Nω-nitro-D-arginine
|
|
|
- CAS-Nr.
- 50913-12-7
- Englisch Name:
- Nα-Boc-Nω-nitro-D-arginine
- Synonyma:
- BOC-D-ARG(NO2)-OH;Boc-D-Arg(NO)-OH;Boc-D-Arg(NO1)-OH;BOC-D-NITROARGININE;Agatraban impurity 1;BOC-D-ARGININE(NITRO);BOC-D-ARGININE(NO2)-OH;Boc-Nw-nitro-D-arginine;N'-Nitro-N-Boc-D-arginine;Na-Boc-N-nitro-D-arginine
- CBNumber:
- CB9699926
- Summenformel:
- C11H21N5O6
- Molgewicht:
- 319.31
- MOL-Datei:
- 50913-12-7.mol
|
Nα-Boc-Nω-nitro-D-arginine Eigenschaften
- Schmelzpunkt:
- 113-126°C (dec.)
- Dichte
- 1.40±0.1 g/cm3(Predicted)
- storage temp.
- -15°C
- L?slichkeit
- Aqueous Base (Slightly), DMSO (Slightly)
- pka
- 3.84±0.50(Predicted)
- Aggregatzustand
- Solid
- Farbe
- White
- Optische Rotation
- Consistent with structure
Sicherheit
Nα-Boc-Nω-nitro-D-arginine Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
White Solid
Verwenden
Nα-Boc-Nω-nitro-D-arginine is used in the synthesis of selective inactivators of human plasma kallikrein via chloromethyl ketone formation. Nα-Boc-Nω-nitro-D-arginine also produced modest inhibition of the effects acetylcholine in rabbit aorta.
Nα-Boc-Nω-nitro-D-arginine Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Nα-Boc-Nω-nitro-D-arginine Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 149)Lieferanten
50913-12-7()Verwandte Suche:
- BOC-D-NITROARGININE
- BOC-D-ARGININE(NITRO)
- BOC-D-ARGININE(NO2)-OH
- BOC-N-OMEGA-NITRO-D-ARGININE
- N-α-Boc-N-ω-nitro-D-arginine
- N-.ALPHA.-BOC-N-.OMEGA.-NITRO-D-ARGININE
- OMEGA-NITRO-BOC-D-ARGININE
- N-ALPHA-T-BUTOXYCARBONYL-N-G-NITRO-D-ARGININE
- N-ALPHA-T-BOC-NG-NITRO-D-ARGININE
- Boc-D-Arg(NO)-OH
- N-alpha-tert-Butoxycarbonyl-N-omega-nitro-D-arginine
- Boc-Nw-nitro-D-arginine
- N'-Nitro-N-Boc-D-arginine
- Boc-D-Arg(NO2)-OH N-α-Boc-N-ω-nitro-D-arginine
- N2-[(1,1-DiMethylethoxy)carbonyl]-N5-[iMino(nitroaMino)Methyl]-D-ornithine
- Na-Boc-Nw-nitro-D-arginine
- Nα-Boc-Nω-nitro-D-arginine≥ 99% (HPLC)
- Agatraban impurity 1
- (2R)-2-{[(tert-butoxy)carbonyl]amino}-5-(N'-nitrocarbamimidamido)pentanoic acid
- (2R)-5-[[amino(nitramido)methylidene]amino]-2-[[(2-methylpropan-2-yl)oxy-oxomethyl]amino]pentanoic acid
- (2R)-5-[[amino(nitramido)methylidene]amino]-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoic acid
- (2R)-2-(tert-butoxycarbonylamino)-5-[(N-nitrocarbamimidoyl)amino]pentanoic acid
- (Tert-Butoxy)Carbonyl D-Arg(NO2)-OH
- D-Ornithine, N2-[(1,1-dimethylethoxy)carbonyl]-N5-[imino(nitroamino)methyl]-
- (2R)-5-[[amino(nitramido)methylidene]amino]-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoicaci
- Nα-Boc-Nω-nitro-D-arginine
- Nα-Boc-Nω-nitro-D-arginine USP/EP/BP
- N2-[(1,1-Dimethylethoxy)carbonyl]-N5-[imino(nitroamino)methyl]-D-ornithine (Afatinib Impurity）
- Na-Boc-N-nitro-D-arginine
- N2-(tert-Butoxycarbonyl)-Nw-nitro-D-arginine
- Agatraban impurity 1(Argatroban Impurity 45)
- Boc-D-Arg(NO1)-OH
- BOC-D-ARG(NO2)-OH
- 50913-12-7
- Amino Acids & Derivatives
- Inhibitors
- Intermediates & Fine Chemicals
- Pharmaceuticals
- Boc-Amino Acids and Derivative
